|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-2-20
|
|
pubmed:abstractText |
Many chronic heart failure (CHF) patients take beta-blockers. When such patients are hospitalized for decompensation, it remains unclear how ongoing beta-blocker treatment will affect outcomes of acute inotrope therapy. We aimed to assess outcomes of SURVIVE patients who were on beta-blocker therapy before receiving a single intravenous infusion of levosimendan or dobutamine.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-10376614,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-11605160,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-11744130,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-11851582,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-12133653,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-12383572,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-12853193,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-15489122,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-15681577,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-15901669,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-16160202,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-16500578,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-17000631,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-17194875,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-17473298,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-17540205,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-18158472,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-20675671,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19158152-8941106
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1388-9842
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
304-11
|
|
pubmed:dateRevised |
2011-6-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19158152-Acute Disease,
pubmed-meshheading:19158152-Adrenergic beta-Antagonists,
pubmed-meshheading:19158152-Aged,
pubmed-meshheading:19158152-Cardiotonic Agents,
pubmed-meshheading:19158152-Cause of Death,
pubmed-meshheading:19158152-Dobutamine,
pubmed-meshheading:19158152-Dose-Response Relationship, Drug,
pubmed-meshheading:19158152-Double-Blind Method,
pubmed-meshheading:19158152-Drug Therapy, Combination,
pubmed-meshheading:19158152-Female,
pubmed-meshheading:19158152-Follow-Up Studies,
pubmed-meshheading:19158152-Heart Failure,
pubmed-meshheading:19158152-Humans,
pubmed-meshheading:19158152-Hydrazones,
pubmed-meshheading:19158152-Infusions, Intravenous,
pubmed-meshheading:19158152-Male,
pubmed-meshheading:19158152-Middle Aged,
pubmed-meshheading:19158152-Pyridazines,
pubmed-meshheading:19158152-Stroke Volume,
pubmed-meshheading:19158152-Survival Rate,
pubmed-meshheading:19158152-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.
|
|
pubmed:affiliation |
Department of Anaesthesiology and Critical Care Medicine, Hôpital Lariboisière, APHP; Université Paris 7 Paris Diderot; U 942 INSERM, 2 rue Ambroise-Paré, Paris Cedex 10 75475, France. alexandre.mebazaa@lrb.aphp.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
